Eli Lilly and Company
For patients prescribed Zepbound or Mounjaro seeking treatment adherence and progress tracking.
Known forLilly Health™
Lilly Health™For patients prescribed Zepbound or Mounjaro seeking treatment adherence and progress tracking.
Lilly Health™Supporting patients on Zepbound and Mounjaro with digital tools to track treatment progress and access educational resources.
Target audience
Rivals analysis in progress
Portfolio
Free 2Last updated
Lilly Health™
v1.5
4mo ago
Primary focus
Digital health companions for pharmaceutical patients
Scale
indie
Target audience
Patients prescribed Zepbound or Mounjaro seeking treatment adherence and progress tracking.
Released 3 updates for their single active title in the last 6 months, with the most recent update occurring 38 days ago.
2 apps analysed
Zepbound & Mounjaro support & resources for savings, tracking & more
Analysis in progress
Single-market publisher — every app ships only to United States.
Based on 1 of 2 apps with localized market data — more coverage rolling in as scans complete · last scanned .
User-sentiment analysis coming soon.
Rival analysis coming soon.
Strategic outlook coming soon.
What fed this analysis